Grier Jeanine T, Batchelor Tracy
Division of Neuro-Oncology, Department of Neurology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA.
Oncologist. 2006 Jun;11(6):681-93. doi: 10.1634/theoncologist.11-6-681.
Low-grade gliomas are a heterogeneous group of neoplasms usually encountered in younger patient populations. These tumors represent a unique challenge because most patients will survive a decade or more and may be at a higher risk for treatment-related complications. Clinical observations over the years have identified a subset of low-grade gliomas that tends to manifest more aggressive clinical behavior and require earlier, more aggressive intervention. Clinical and molecular parameters may allow better assessment of prognosis and application of risk-adjusted management strategies that may include resection, radiation, or chemotherapy. Improved methods of long-term cognitive and functional assessment are desperately needed in this patient population.
低级别胶质瘤是一组异质性肿瘤,通常见于较年轻的患者群体。这些肿瘤带来了独特的挑战,因为大多数患者将存活十年或更长时间,并且可能面临更高的治疗相关并发症风险。多年来的临床观察发现,一部分低级别胶质瘤往往表现出更具侵袭性的临床行为,需要更早、更积极的干预。临床和分子参数可能有助于更好地评估预后,并应用风险调整管理策略,其中可能包括手术切除、放疗或化疗。在这一患者群体中,迫切需要改进长期认知和功能评估方法。